皇家製藥公司 - 資產負債表 (Quarterly)

皇家製藥公司
MX ˙ BMV ˙ GB00BMVP7Y09
資產負債表 (Quarterly)

皇家製藥公司資產負債表反映公司在特定時間點的帳戶餘額。財務狀況表數據包括資產、流動資產、固定資產、不動產、廠房和設備(PPE)、存貨、無形資產、負債、流動負債、長期負債、融資租賃負債、普通股、保留盈利、庫存股和股東權益。

除以每股為單位的數字外,所有數字為1,000,000.00倍數。

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
現金 1,142 1,801 1,541 1,792 2,108 992 1,711 1,976 2,173 936 477 843 1,765 950 929 1,088 632 939 619 586
改變 (%) 57.65 -14.42 16.25 17.67 -52.96 72.52 15.49 9.99 -56.91 -49.06 76.73 109.33 -46.16 -2.21 17.08 -41.91 48.59 -34.11 -5.22
流動資產 2,707 2,776 2,878 2,982 3,504 2,342 2,555 2,631 2,954 1,729 1,274 1,560 2,579 1,794 1,802 1,843 1,520 1,850 1,528 1,426
改變 (%) 2.52 3.69 3.62 17.48 -33.16 9.09 2.99 12.25 -41.47 -26.29 22.41 65.36 -30.43 0.44 2.28 -17.52 21.66 -17.38 -6.69
資產 16,515 17,732 17,516 17,379 17,740 17,673 16,813 17,074 17,121 15,856 16,382 16,131 17,657 18,042 18,223 17,608 18,323 19,347 19,621 19,815
改變 (%) 7.37 -1.22 -0.78 2.08 -0.38 -4.86 1.55 0.28 -7.39 3.32 -1.53 9.46 2.18 1.00 -3.37 4.06 5.59 1.41 0.99
負債 6,110 7,346 7,267 7,237 7,332 7,256 7,288 7,252 7,308 6,270 6,298 6,267 7,905 7,784 7,880 7,820 8,820 9,726 9,906 9,879
改變 (%) 20.23 -1.07 -0.42 1.32 -1.04 0.44 -0.49 0.77 -14.20 0.43 -0.48 26.13 -1.53 1.24 -0.77 12.79 10.28 1.84 -0.28
公平 10,405 10,387 10,249 10,142 10,408 10,416 9,525 9,822 9,814 9,585 10,084 9,864 9,752 10,258 10,342 9,789 9,503 9,621 9,715 9,937
改變 (%) -0.18 -1.33 -1.04 2.63 0.08 -8.55 3.11 -0.08 -2.33 5.21 -2.19 -1.13 5.20 0.82 -5.35 -2.92 1.24 0.98 2.28
負債和股本 16,515 17,732 17,516 17,379 17,740 17,673 16,813 17,074 17,121 15,856 16,382 16,131 17,657 18,042 18,223 17,608 18,323 19,347 19,621 19,815
改變 (%) 7.37 -1.22 -0.78 2.08 -0.38 -4.86 1.55 0.28 -7.39 3.32 -1.53 9.46 2.18 1.00 -3.37 4.06 5.59 1.41 0.99

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:RPD €47.00
US:RPRX US$55.87
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista